Facebook
Twitter
Telegram
Report an ErrorGalectin Therapeutics Cash Flow 2011-2024 | GALT
Annual Cash Flow Galectin Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-33 M | -31.1 M | -24.3 M | -20.6 M | -10.8 M | -10.2 M | -15.9 M | - | - | - | -7.48 M | -7.5 M | -5.68 M |
Depreciation & Amortization |
- | - | - | - | - | - | 1 K | 7 K | 7 K | 10 K | 12 K | 9 K | 9 K |
Accounts Payables |
6.43 M | 3.89 M | 1.8 M | 1.29 M | 1.66 M | 297 K | 608 K | 910 K | 448 K | 906 K | 762 K | 397 K | 384 K |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Galectin Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-12.1 M | - | - | - | -10.8 M | - | -23.8 M | -15.5 M | -8.04 M | - | -17.4 M | -12.4 M | -6.38 M | - | -15.2 M | -6.98 M | -4.37 M | - | -7.09 M | -5.61 M | -3.28 M | - | -8.17 M | -6.6 M | -3.52 M | - | -12 M | -8.86 M | - | - | - | - | - | - | - | - | - | - | - | - | -3.62 M | - | - | - | -2.42 M | - | -5.75 M | -3.67 M | -1.49 M | - | -4.13 M | -2.88 M | -1.37 M |
Depreciation & Amortization |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1 K | 1 K | 1 K | - | 5 K | 3 K | 1 K | - | 6 K | 4 K | 2 K | - | 8 K | 5 K | 2 K | - | 9 K | 6 K | 3 K | - | 5 K | 4 K | 2 K | - | 7 K | 5 K | 2 K |
Accounts Payables |
3.8 M | 6.43 M | 2.68 M | 1.98 M | 2.55 M | 3.89 M | 2.35 M | 2.96 M | 1.91 M | 1.8 M | 1.92 M | 924 K | 382 K | 1.29 M | 1.29 M | 1.29 M | 1.29 M | 1.66 M | 1.66 M | 1.66 M | 1.66 M | 297 K | 297 K | 297 K | 297 K | 608 K | 608 K | 608 K | 608 K | 910 K | 910 K | 910 K | 910 K | 448 K | 448 K | 448 K | 448 K | 906 K | 906 K | 906 K | 906 K | 762 K | 762 K | 762 K | 762 K | 397 K | 397 K | 397 K | 397 K | 384 K | 384 K | 384 K | 384 K |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency